PATENT CLAIM ANALYSIS

Application Number: 15781276
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "006110"]

Abstract:
Provided is a method for predicting an individual to be at risk of developing sudden unexpected death in epilepsy (SUDEP) comprising determining the presence or absence of mutations in the genes ITPR1, GABRR2, JUP, SSTR5, F2, KCNMB1, CNTNAP2, GRM8, GNAI2, TUBA3D, GRIK1, GRIK5 and DPP6, or determining if the expression of certain cardiac arrhythmia genes or gamma-aminobutyric acid/glutamate metabolism genes are increased or decreased.

Claim (Index 6):
The method of  claim 1 , wherein if the individual is identified as having one or more SUDEP specific mutations in the genes ITPR1, GABRR2, SSTR5, CNTNAP2, GRM8, GNAI2, GRIK1 or GRIK5, then the individual is further administered a gamma aminobutyric acid (GABA) receptor agonist, GABA reuptake inhibitor, a GABA transaminase inhibitor, or a glutamate blocker.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.38596
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14506565', '14672066', '14512306', '14329639', '14020811']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6076550893313472
- 35 USC 102 Novelty (BERT): 0.5114345982509316
- Combined Prediction Score: 0.5980330402233056
- Mean Citation Score: 199.939602
- Max Citation Score: 205.78165
- Similarity Product: 108.37054181410372

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test